Literature DB >> 32527136

Large pulmonary cavity in COVID-19 cured patient case report.

Ying Chen1, Wanling Chen1, Jiansheng Zhou2, Cong Sun3, Yujie Lei1.   

Abstract

Coronavirus Disease 2019 (COVID-19) is a pneumonia caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The outbreak began in Wuhan, China, and spread rapidly, with many cases confirmed in multiple countries. Usually, after viral pneumonia were clinical cured, the pulmonary lesions of majority patients will gradually be absorbed to complete dissipation, very few severe patients may retain pulmonary interstitial inflammation and fibrosis. In this case, we described one unique COVID-19 patient, the symptoms were: dry cough, fatigue, poor appetite and subjective fever, moreover, the patient was a non-smoker, had no pulmonary bullous, no history of tuberculosis, and also no hypertension or diabetes. The patient received antiviral therapy, antibacterial therapy, recombinant human interferon-α2a, vitamin C and oxygen inhalation. After two weeks of treatment and observation, the patient was clinical cured and discharged. However, two days later, the patient had a sudden chest stuffiness, CT images indicted: his lung didn't heal like others, but developed a large pulmonary cavity in the lower lobe of right lung. In hospital, the patient showed no symptoms of infection for another 14 days, and the pulmonary cavity remain unchanged. This case suggested: it is important to follow convalescent COVID-19 patients, especially their lung CT images, to make sure a fully recovery.

Entities:  

Keywords:  Coronavirus Disease 2019 (COVID-19); case report; pulmonary cavity; severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)

Mesh:

Year:  2020        PMID: 32527136     DOI: 10.21037/apm-20-452

Source DB:  PubMed          Journal:  Ann Palliat Med        ISSN: 2224-5820


  6 in total

1.  Lung cavitation due to COVID-19 pneumonia.

Authors:  Vijairam Selvaraj; Kwame Dapaah-Afriyie
Journal:  BMJ Case Rep       Date:  2020-07-06

2.  Study to assess aetiology, clinical and imaging characteristics of post Covid-19 pulmonary cavitation.

Authors:  Deependra Kumar Rai; Rajeev K Priyadarshi; Saurabh Karmaker
Journal:  J Family Med Prim Care       Date:  2022-02-16

3.  Biofilms possibly harbor occult SARS-CoV-2 may explain lung cavity, re-positive and long-term positive results.

Authors:  Daqian He; Chaojiang Fu; Mingjie Ning; Xianglin Hu; Shanshan Li; Ying Chen
Journal:  Front Cell Infect Microbiol       Date:  2022-09-28       Impact factor: 6.073

Review 4.  COVID-19 and pulmonary fibrosis: therapeutics in clinical trials, repurposing, and potential development.

Authors:  Joowon Yim; Hee Hyun Lim; Youngjoo Kwon
Journal:  Arch Pharm Res       Date:  2021-05-28       Impact factor: 6.010

5.  Simultaneous Giant cavity pulmonary lesion and pneumothorax following COVID-19 pneumonia.

Authors:  Ramezan Jafari; Luca Cegolon; Houshyar Masghsoudi; Shi Zhao; Saeid Fathi; Leila Khedmat; Mohammad Javanbakht
Journal:  Radiol Case Rep       Date:  2021-06-14

6.  Development of a Large Pneumatocele in a Patient Recovering from COVID-19 Pneumonitis.

Authors:  Frances Hampson; Waleed Salih; Jennifer Helm
Journal:  Eur J Case Rep Intern Med       Date:  2021-06-28
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.